Patents by Inventor Thomas K. Waddell

Thomas K. Waddell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9944950
    Abstract: A method of generating an induced progenitor population (iPP) of cells and/or induced population of cells from somatic cells, comprising the steps: a) obtaining a starting cell population, wherein cells of the starting cell population comprise, or are contacted with, a nucleic acid molecule encoding four reprogramming factors under the control of a control element, wherein the four reprogramming factors are optionally Oct4, Klf4, Sox2 and c-Myc, and wherein the control element prevents or stops expression of the reprogramming factors under its control in the absence of induction by an inducing agent; and b) transiently inducing expression of the reprogramming factors in the starting cell population to obtain an iPP, c) optionally isolating the iPP, and d) terminating the transient induction while the proliferative capacity of the iPP remains under the control of the one or more exogenous reprogramming factors to produce an induced population of cells.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: April 17, 2018
    Inventors: Thomas K. Waddell, Li Guo, Andras Nagy
  • Publication number: 20150004612
    Abstract: A method of generating an induced progenitor population (iPP) of cells and/or induced population of cells from somatic cells, comprising the steps: a) obtaining a starting cell population, wherein cells of the starting cell population comprise, or are contacted with, a nucleic acid molecule encoding four reprogramming factors under the control of a control element, wherein the four reprogramming factors are optionally Oct4, Klf4, Sox2 and c-Myc, and wherein the control element prevents or stops expression of the reprogramming factors under its control in the absence of induction by an inducing agent; and b) transiently inducing expression of the reprogramming factors in the starting cell population to obtain an iPP, c) optionally isolating the iPP, and d) terminating the transient induction while the proliferative capacity of the iPP remains under the control of the one or more exogenous reprogramming factors to produce an induced population of cells.
    Type: Application
    Filed: June 3, 2014
    Publication date: January 1, 2015
    Inventors: Thomas K. Waddell, Li Guo, Andras Nagy
  • Publication number: 20130143323
    Abstract: A biomedical device and method provide for decullularization, recellularization or other treatment of an organ of a human or animal. To keep pressures to a minimum and to ensure that the perfusion fluid uniformly perfused the organ, the organ is supported and rotated during the perfusion process. The organ is supported by a medium, which may comprise a liquid or pallets in a vessel, with a vessel mounted for limited rotation. The perfusion tubing, for supply of perfusion fluid to inform the organ can be mounted both to a support structure and the vessel. The perfusion system can include tubing for supply of air or an air substitute.
    Type: Application
    Filed: June 1, 2012
    Publication date: June 6, 2013
    Inventors: Geoffrey S. FROST, Thomas K. WADDELL
  • Patent number: 8247175
    Abstract: Methods and compositions for determining the suitability of a lung for transplantation are described.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: August 21, 2012
    Assignee: University Health Network
    Inventors: Shaf Keshavjee, Thomas K. Waddell, Mingyao Liu